Doç. Dr. CÜNEYT TÜRKEŞ

Yayın Ağı

Makaleler 61

1. Rhodanine–Sulfonate hybrids targeting aldose reductase: Synthesis, in vitro inhibition, molecular docking, and cytotoxicity studies

Kalay E., Demir Y., TÜRKEŞ C., ASLAN O. N., PEZİK E., Şahin E.

Molecular Diversity , 2025 (SCI-Expanded, Scopus)

2. Carbonic anhydrase inhibition by antiviral drugs in vitro and in silico

TÜRKEŞ C.

Journal of Molecular Recognition , cilt.36, sa.12, 2023 (SCI-Expanded)

3. Synthesis, Theoretical, in Silico and in Vitro Biological Evaluation Studies of New Thiosemicarbazones as Enzyme Inhibitors

Erdoğan M., Serdar Çavuş M., Muğlu H., Yakan H., Türkeş C., Demir Y., et al.

Chemistry and Biodiversity , cilt.20, sa.11, 2023 (SCI-Expanded)

4. Synthesis and characterization of novel acyl hydrazones derived from vanillin as potential aldose reductase inhibitors

Demir Y., Tokalı F. S., Kalay E., Türkeş C., Tokalı P., Aslan O. N., et al.

Molecular Diversity , cilt.27, sa.4, ss.1713-1733, 2023 (SCI-Expanded) Sürdürülebilir Kalkınma

5. Synthesis and Characterization of Novel 1,3-Diaryltriazene-Substituted Sulfaguanidine Derivatives as Selective Carbonic Anhydrase Inhibitors: Biological Evaluation, in Silico ADME/T and Molecular Docking Study

Akocak S., Lolak N., Duran H. E., Işık M., Türkeş C., Durgun M., et al.

Chemistry and Biodiversity , cilt.20, sa.8, 2023 (SCI-Expanded) Sürdürülebilir Kalkınma

6. Novel bis-ureido-substituted sulfaguanidines and sulfisoxazoles as carbonic anhydrase and acetylcholinesterase inhibitors

Lolak N., Akocak S., Durgun M., Duran H. E., Necip A., Türkeş C., et al.

Molecular Diversity , cilt.27, sa.4, ss.1735-1749, 2023 (SCI-Expanded) Sürdürülebilir Kalkınma

7. Discovery of novel benzenesulfonamides incorporating 1,2,3-triazole scaffold as carbonic anhydrase I, II, IX, and XII inhibitors

Buza A., Türkeş C., Arslan M., Demir Y., Dincer B., Nixha A. R., et al.

International Journal of Biological Macromolecules , cilt.239, 2023 (SCI-Expanded) Sürdürülebilir Kalkınma

8. A novel series of thiosemicarbazone hybrid scaffolds: Design, synthesis, DFT studies, metabolic enzyme inhibition properties, and molecular docking calculations

Yakan H., Muğlu H., Türkeş C., Demir Y., Erdoğan M., Çavuş M. S., et al.

Journal of Molecular Structure , cilt.1280, 2023 (SCI-Expanded)

9. Enzyme inhibition, molecular docking, and density functional theory studies of new thiosemicarbazones incorporating the 4-hydroxy-3,5-dimethoxy benzaldehyde motif

Demir Y., Türkeş C., Çavuş M. S., Erdoğan M., Muğlu H., Yakan H., et al.

Archiv der Pharmazie , cilt.356, sa.4, 2023 (SCI-Expanded)

10. Novel acetic acid derivatives containing quinazolin-4(3H)-one ring: Synthesis, in vitro, and in silico evaluation of potent aldose reductase inhibitors

Tokalı F. S., Demir Y., Türkeş C., Dincer B., Beydemir Ş.

Drug Development Research , cilt.84, sa.2, ss.275-295, 2023 (SCI-Expanded)

11. A new series of hydrazones as small-molecule aldose reductase inhibitors

Altıntop M. D., Demir Y., Türkeş C., Öztürk Başpınar N., Cantürk Z., Beydemir Ş., et al.

Archiv der Pharmazie , cilt.356, sa.4, 2023 (SCI-Expanded)

12. The synthesis, biological evaluation and in silico studies of asymmetric 3,5-diaryl-rhodanines as novel inhibitors of human carbonic anhydrase isoenzymes

Yararli K., Ozer E. B., Bayindir S., ÇAĞLAYAN C., TÜRKEŞ C., BEYDEMİR Ş.

Journal of Molecular Structure , cilt.1276, 2023 (SCI-Expanded)

13. Exploration of Some Bis-Sulfide and Bis-Sulfone Derivatives as Non-Classical Aldose Reductase İnhibitors

Türkeş C., Demir Y., Biçer A., Cin G. T., Gültekin M. S., Beydemir Ş.

ChemistrySelect , cilt.8, sa.5, 2023 (SCI-Expanded)

14. Exploration of 1,2,3-triazole linked benzenesulfonamide derivatives as isoform selective inhibitors of human carbonic anhydrase

Kakakhan C., Türkeş C., Güleç Ö., Demir Y., Arslan M., Özkemahlı G., et al.

Bioorganic and Medicinal Chemistry , cilt.77, 2023 (SCI-Expanded)

15. Molecular Docking Studies and the Effect of Fluorophenylthiourea Derivatives on Glutathione-Dependent Enzymes

Demir Y., TÜRKEŞ C., KÜFREVİOĞLU Ö. İ., BEYDEMİR Ş.

Chemistry and Biodiversity , cilt.20, sa.1, 2023 (SCI-Expanded) Sürdürülebilir Kalkınma

16. Synthesis, characterization and docking studies of benzenesulfonamide derivatives containing 1,2,3-triazole as potential ınhibitor of carbonic anhydrase I-II enzymes

Güngör S. A., Köse M., Tümer M., Türkeş C., Beydemir Ş.

Journal of Biomolecular Structure and Dynamics , cilt.41, sa.20, ss.10919-10929, 2023 (SCI-Expanded)

17. In Vitro Inhibitory Activity and Molecular Docking Study of Selected Natural Phenolic Compounds as AR and SDH Inhibitors**

Türkeş C., Demir Y., Beydemir Ş.

CHEMISTRYSELECT , cilt.7, sa.48, ss.202204050, 2022 (SCI-Expanded)

18. N-substituted phthalazine sulfonamide derivatives as non-classical aldose reductase inhibitors.

Türkeş C., Arslan M., Demir Y., Çoçaj L., Nıxha A. R., Beydemir Ş.

Journal of molecular recognition : JMR , cilt.35, sa.12, 2022 (SCI-Expanded) Sürdürülebilir Kalkınma

19. Ophthalmic drugs: in vitro paraoxonase 1 inhibition and molecular docking studies

Çalışkan B., Demir Y., Türkeş C.

Biotechnology and Applied Biochemistry , cilt.69, sa.6, ss.2273-2283, 2022 (SCI-Expanded) Sürdürülebilir Kalkınma

20. Biological evaluation and in silico study of benzohydrazide derivatives as paraoxonase 1 inhibitors

Korkmaz I. N., TÜRKEŞ C., Demir Y., Öztekin A., ÖZDEMİR H., BEYDEMİR Ş.

Journal of Biochemical and Molecular Toxicology , cilt.36, sa.11, 2022 (SCI-Expanded)

21. Cytotoxic effect, enzyme inhibition, and in silico studies of some novel N-substituted sulfonyl amides incorporating 1,3,4-oxadiazol structural motif

Güleç Ö., Türkeş C., Arslan M., Demir Y., Yeni Y., Hacımüftüoğlu A., et al.

Molecular Diversity , cilt.26, sa.5, ss.2825-2845, 2022 (SCI-Expanded)

22. Methyl benzoate derivatives: in vitro Paraoxonase 1 inhibition and in silico studies

Korkmaz I. N., TÜRKEŞ C., Demir Y., ÖZDEMİR H., BEYDEMİR Ş.

Journal of Biochemical and Molecular Toxicology , cilt.36, sa.10, 2022 (SCI-Expanded)

23. Design, synthesis, and biological activity of novel dithiocarbamate-methylsulfonyl hybrids as carbonic anhydrase inhibitors

Osmaniye D., Türkeş C., Demir Y., Özkay Y., Beydemir Ş., Kaplancıklı Z. A.

Archiv der Pharmazie , cilt.355, sa.8, 2022 (SCI-Expanded)

24. Synthesis, biological evaluation, and in silico study of novel library sulfonates containing quinazolin-4(3H)-one derivatives as potential aldose reductase inhibitors

Tokali F. S., Demir Y., Demircioglu I. H., Türkeş C., Kalay E., Sendil K., et al.

Drug Development Research , cilt.83, sa.3, ss.586-604, 2022 (SCI-Expanded)

25. **Some calcium-channel blockers: kinetic and in silico studies on paraoxonase-I.**

Türkeş C., Demir Y., Beydemir Ş.

Journal of biomolecular structure & dynamics , cilt.40, sa.1, ss.77-85, 2022 (SCI-Expanded) Sürdürülebilir Kalkınma

26. Novel inhibitors with sulfamethazine backbone: synthesis and biological study of multi-target cholinesterases and α-glucosidase inhibitors

Türkeş C., Akocak S., Işık M., Lolak N., Taslimi P., Durgun M., et al.

Journal of Biomolecular Structure and Dynamics , cilt.40, sa.19, ss.8752-8764, 2022 (SCI-Expanded) Sürdürülebilir Kalkınma

27. Molecular docking and inhibition studies of vulpinic, carnosic and usnic acids on polyol pathway enzymes

Demir Y., Ceylan H., Türkeş C., Beydemir Ş.

Journal of Biomolecular Structure and Dynamics , cilt.40, sa.22, ss.12008-12021, 2022 (SCI-Expanded) Sürdürülebilir Kalkınma

28. Novel metabolic enzyme inhibitors designed through the molecular hybridization of thiazole and pyrazoline scaffolds.

Sever B., Türkeş C., Altıntop M. D., Demir Y., Akalın Çiftçi G., Beydemir Ş.

Archiv der Pharmazie , cilt.354, sa.12, 2021 (SCI-Expanded)

29. Infection Medications: Assessment In-Vitro Glutathione S-Transferase Inhibition and Molecular Docking Study

TÜRKEŞ C., Demir Y., Beydemir Ş.

ChemistrySelect , cilt.6, sa.43, ss.11915-11924, 2021 (SCI-Expanded) Sürdürülebilir Kalkınma

30. Biological effects of bis-hydrazone compounds bearing isovanillin moiety on the aldose reductase.

Yapar G., Esra Duran H., Lolak N., Akocak S., Türkeş C., Durgun M., et al.

Bioorganic chemistry , cilt.117, ss.105473, 2021 (SCI-Expanded)

31. Calcium Channel Blockers: The Effect of Glutathione S-Transferase Enzyme Activity and Molecular Docking Studies

TÜRKEŞ C., Kesebir A. Ö., Demir Y., KÜFREVİOĞLU Ö. İ., Beydemir Ş.

ChemistrySelect , cilt.6, sa.40, ss.11137-11143, 2021 (SCI-Expanded) Sürdürülebilir Kalkınma

32. Benzenesulfonamide derivatives as potent acetylcholinesterase, alpha-glycosidase, and glutathione S-transferase inhibitors: biological evaluation and molecular docking studies

Taslimi P., Işık M., Türkan F., Durgun M., Türkeş C., Gülçin İ., et al.

JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS , cilt.39, sa.15, ss.5449-5460, 2021 (SCI-Expanded)

33. Transition-Metal Complexes of Bidentate Schiff-Base Ligands: In Vitro and In Silico Evaluation as Non-Classical Carbonic Anhydrase and Potential Acetylcholinesterase Inhibitors

Yaşar Ü., Gönül İ., Türkeş C., Demir Y., Beydemir Ş.

ChemistrySelect , cilt.6, sa.29, ss.7278-7284, 2021 (SCI-Expanded)

34. Design, synthesis, characterization, in vitro and in silico evaluation of novel imidazo[2,1-b][1,3,4]thiadiazoles as highly potent acetylcholinesterase and non-classical carbonic anhydrase inhibitors

Askin S., Tahtaci H., Türkeş C., Demir Y., Ece A., Akalın Çiftçi G., et al.

BIOORGANIC CHEMISTRY , cilt.113, 2021 (SCI-Expanded)

35. Synthesis, characterization, and inhibition study of novel substituted phenylureido sulfaguanidine derivatives as α-glycosidase and cholinesterase inhibitors.

Akocak S., Taslimi P., Lolak N., Işık M., Durgun M., Budak Y., et al.

Chemistry & biodiversity , cilt.18, 2021 (SCI-Expanded) Sürdürülebilir Kalkınma

36. Novel benzoic acid derivatives: Synthesis and biological evaluation as multitarget acetylcholinesterase and carbonic anhydrase inhibitors.

Kalaycı M., Türkeş C., Arslan M., Demir Y., Beydemir Ş.

Archiv der Pharmazie , cilt.354, 2021 (SCI-Expanded) Sürdürülebilir Kalkınma

37. A new series of 2,4-thiazolidinediones endowed with potent aldose reductase inhibitory activity

Sever B., Altlntop M. D., Demir Y., Türkeş C., Özbaş K., Çiftçi G. A., et al.

Open Chemistry , cilt.19, sa.1, ss.347-357, 2021 (SCI-Expanded)

38. Calcium channel blockers: molecular docking and inhibition studies on carbonic anhydrase I and II isoenzymes

Türkeş C., Demir Y., Beydemir S.

Journal of Biomolecular Structure and Dynamics , cilt.39, sa.5, ss.1672-1680, 2021 (SCI-Expanded)

39. Gadolinium-based contrast agents: in vitro paraoxonase 1 inhibition, in silico studies

Beydemir Ş., Türkeş C., Yalçın A.

Drug and Chemical Toxicology , cilt.44, sa.5, ss.508-517, 2021 (SCI-Expanded) Sürdürülebilir Kalkınma

40. Mannich reaction derived novel boron complexes with amine-bis(phenolate) ligands: Synthesis, spectroscopy and in vitro/in silico biological studies

Kilic A., Beyazsakal L., Işık M., Türkeş C., Necip A., Takım K., et al.

Journal of Organometallic Chemistry , cilt.927, 2020 (SCI-Expanded)

41. Thiazolyl-pyrazoline derivatives: In vitro and in silico evaluation as potential acetylcholinesterase and carbonic anhydrase inhibitors.

Sever B., Türkeş C., Altıntop M., Demir Y., Beydemir Ş.

International journal of biological macromolecules , cilt.163, ss.1970-1988, 2020 (SCI-Expanded) Sürdürülebilir Kalkınma

42. Synthesis, characterization, biological evaluation, and in silico studies of novel 1,3-diaryltriazene-substituted sulfathiazole derivatives

Isik M., Akocak S., Lolak N., Taslimi P., Türkeş C., Gülçin İ., et al.

ARCHIV DER PHARMAZIE , cilt.353, sa.9, 2020 (SCI-Expanded)

43. Synthesis, characterization, inhibition effects, and molecular docking studies as acetylcholinesterase, ?-glycosidase, and carbonic anhydrase inhibitors of novel benzenesulfonamides incorporating 1,3,5-triazine structural motifs

Lolak N., Akocak S., Türkeş C., Taslimi P., Isik M., Beydemir S., et al.

BIOORGANIC CHEMISTRY , cilt.100, 2020 (SCI-Expanded)

44. Sulfonamides incorporating ketene N,S-acetal bioisosteres as potent carbonic anhydrase and acetylcholinesterase inhibitors

Istrefi Q., Türkeş C., Arslan M., Demir Y., Nixha A. R., Beydemir S., et al.

ARCHIV DER PHARMAZIE , cilt.353, sa.6, 2020 (SCI-Expanded) Sürdürülebilir Kalkınma

45. Molecular docking and investigation of 4-(benzylideneamino)- and 4-(benzylamino)-benzenesulfonamide derivatives as potent AChE inhibitors

Işık M., Demir Y., Durgun M., Türkeş C., Necip A., Beydemir Ş.

CHEMICAL PAPERS , cilt.74, sa.5, ss.1395-1405, 2020 (SCI-Expanded)

46. Benzenesulfonamide derivatives containing imine and amine groups: Inhibition on human paraoxonase and molecular docking studies

Isik M., Beydemir S., Demir Y., Durgun M., Türkeş C., Nasir A., et al.

INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES , cilt.146, ss.1111-1123, 2020 (SCI-Expanded)

47. Inhibition of Human Serum Paraoxonase-I with Antimycotic Drugs: In Vitro and In Silico Studies

Türkeş C., Beydemir S.

APPLIED BIOCHEMISTRY AND BIOTECHNOLOGY , cilt.190, sa.1, ss.252-269, 2020 (SCI-Expanded) Sürdürülebilir Kalkınma

48. Synthesis, characterisation, biological evaluation and in silico studies of sulphonamide Schiff bases

Durgun M., Türkeş C., Isik M., Demir Y., Sakli A., Kuru A., et al.

JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY , cilt.35, sa.1, ss.950-962, 2020 (SCI-Expanded)

49. Molecular Docking Studies and Inhibition Properties of Some Antineoplastic Agents against Paraoxonase-I.

Demir Y., Türkeş C., Beydemir Ş.

Anti-cancer agents in medicinal chemistry , cilt.20, ss.887-896, 2020 (SCI-Expanded)

50. New Isoindole-1,3-dione Substituted Sulfonamides as Potent Inhibitors of Carbonic Anhydrase and Acetylcholinesterase: Design, Synthesis, and Biological Evaluation

Gundogdu S., Türkeş C., Arslan M., Demir Y., Beydemir S.

CHEMISTRYSELECT , cilt.4, sa.45, ss.13347-13355, 2019 (SCI-Expanded)

51. A potential risk factor for paraoxonase 1: in silico and in-vitro analysis of the biological activity of proton-pump inhibitors

Türkeş C.

JOURNAL OF PHARMACY AND PHARMACOLOGY , cilt.71, sa.10, ss.1553-1564, 2019 (SCI-Expanded)

52. In Vitro and In Silico Studies on the Toxic Effects of Antibacterial Drugs as Human Serum Paraoxonase 1 Inhibitor

Türkeş C., Beydemir Ş., Küfrevioğlu Ö. İ.

CHEMISTRYSELECT , cilt.4, sa.33, ss.9731-9736, 2019 (SCI-Expanded)

53. Anti-diabetic Properties of Calcium Channel Blockers: Inhibition Effects on Aldose Reductase Enzyme Activity

Türkeş C., Demir Y., Beydemir Ş.

APPLIED BIOCHEMISTRY AND BIOTECHNOLOGY , cilt.189, sa.1, ss.318-329, 2019 (SCI-Expanded) Sürdürülebilir Kalkınma

54. Synthesis, biological evaluation and in silico studies of novel N-substituted phthalazine sulfonamide compounds as potent carbonic anhydrase and acetylcholinesterase inhibitors

Türkeş C., Arslan M., Demir Y., Cocaj L., Nixha A. R., Beydemir Ş.

BIOORGANIC CHEMISTRY , cilt.89, 2019 (SCI-Expanded) Sürdürülebilir Kalkınma

55. Inhibition Effects of Phenolic Compounds on Human Serum Paraoxonase-1 Enzyme

Türkeş C.

Journal of the Institute of Science and Technology , cilt.9, sa.2, ss.1013-1022, 2019 (Hakemli Dergi)

56. Investigation of Potential Paraoxonase-I Inhibitors by Kinetic and Molecular Docking Studies: Chemotherapeutic Drugs

Türkeş C.

PROTEIN AND PEPTIDE LETTERS , cilt.26, sa.6, ss.392-402, 2019 (SCI-Expanded) Sürdürülebilir Kalkınma

57. In vitro inhibitory effects of palonosetron hydrochloride, bevacizumab and cyclophosphamide on purified paraoxonase-I (hPON1) from human serum

Türkeş C., Söyüt H., Beydemir Ş.

ENVIRONMENTAL TOXICOLOGY AND PHARMACOLOGY , cilt.42, ss.252-257, 2016 (SCI-Expanded)

58. Human serum paraoxonase-1 (hPON1): in vitro inhibition effects of moxifloxacin hydrochloride, levofloxacin hemihidrate, cefepime hydrochloride, cefotaxime sodium and ceftizoxime sodium

Türkeş C., Söyüt H., Beydemir Ş.

JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY , cilt.30, sa.4, ss.622-628, 2015 (SCI-Expanded)

59. Effect of calcium channel blockers on paraoxonase-1 (PON1) activity and oxidative stress

Türkeş C., Söyüt H., Beydemir Ş.

PHARMACOLOGICAL REPORTS , cilt.66, sa.1, ss.74-80, 2014 (SCI-Expanded)

60. Inhibition Effects of Gemcitabine Hydrochloride, Acyclovir, and 5-Fluorouracil on Human Serum Paraoxonase-1 (hPON1): In Vitro

Türkeş C., Söyüt H., Beydemir Ş.

Open Journal of Biochemistry , cilt.1, sa.1, ss.10-15, 2013 (Hakemli Dergi)

61. Synthesis and paroxonase activities of novel bromophenols

Akbaba Y., Türkeş C., Polat L., Söyüt H., Şahin E., Menzek A., et al.

JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY , cilt.28, sa.5, ss.1073-1079, 2013 (SCI-Expanded)

Hakemli Bilimsel Toplantılarda Yayımlanmış Bildiriler 56

1. ANTICHOLINERGIC POTENTIAL OF SOME METAL COMPLEXES

Tuna Yıldırım S., Türkeş C., Topal F., Topal M., Merkit K., Beydemir Ş.

8th International Conference on Natural and Engineering Sciences (ICNES 2023), Ankara, Türkiye, 21 - 23 Kasım 2023, cilt.8, sa.1, ss.32, (Özet Bildiri) Sürdürülebilir Kalkınma

2. Determination of the Inhibition Effects of Some Newly Synthesized Schiff Bases on Lipoxygenase Enzyme Activity Quinoa (Chenopodium Quinoa Willd.)

Ereminsoy E., Demir Y., Tuna Yıldırım S., Türkeş C., Küfrevioğlu Ö. İ.

5. Eurasia Biochemical Approaches & Technologies Congress (EBAT 2023), Antalya, Türkiye, 2 - 05 Kasım 2023, cilt.5, sa.1, ss.159, (Özet Bildiri) Sürdürülebilir Kalkınma

3. Evaluation of Antioxidant Potential of Some Schiff Base Metal Complexes

Tuna Yıldırım S., Türkeş C., Topal M., Topal F., Beydemir Ş.

5. Eurasia Biochemical Approaches & Technologies Congress (EBAT 2023), Antalya, Türkiye, 2 - 05 Kasım 2023, cilt.5, sa.1, ss.188, (Özet Bildiri) Sürdürülebilir Kalkınma

4. Some Metal Complexes Containing Schiff Base: Synthesis and Bioactivity Study

Topal M., Tuna Yıldırım S., Türkeş C., Topal F., Beydemir Ş.

5. Eurasia Biochemical Approaches & Technologies Congress (EBAT 2023), Antalya, Türkiye, 2 - 05 Kasım 2023, cilt.5, sa.1, ss.189, (Özet Bildiri) Sürdürülebilir Kalkınma

5. Assessment of Anticholinergic Properties of Some Schiff Base Metal Complexes

Topal F., Tuna Yıldırım S., Türkeş C., Topal M., Beydemir Ş.

5. Eurasia Biochemical Approaches & Technologies Congress (EBAT 2023), Antalya, Türkiye, 2 - 05 Kasım 2023, cilt.5, sa.1, ss.161, (Özet Bildiri) Sürdürülebilir Kalkınma

6. Synthesis and Antioxidant Capacity of Some Metal Complexes

Tuna Yıldırım S., Türkeş C., Topal F., Topal M., Beydemir Ş.

5. Eurasia Biochemical Approaches & Technologies Congress (EBAT 2023), Antalya, Türkiye, 2 - 05 Kasım 2023, cilt.5, sa.1, ss.162, (Özet Bildiri) Sürdürülebilir Kalkınma

7. Synthesis, Characterization, and Enzyme Activity of a New Series Schiff Base Metal Complex

Tuna Yıldırım S., Türkeş C., Topal M., Topal F., Eroğlu O., Beydemir Ş.

6th International Eurasian Conference on Biological and Chemical Sciences (EurasianBioChem 2023), Ankara, Türkiye, 11 - 13 Ekim 2023, cilt.6, sa.1, ss.432, (Özet Bildiri) Sürdürülebilir Kalkınma

8. Interaction of carbonic anhydrase isozymes I and II with antibiotic agent gatifloxacin

KARATAŞ S., TÜRKEŞ C.

5th International Eurasian Conference on Biological and Chemical Sciences (EurasianBioChem 2022), Ankara, Türkiye, 23 - 25 Kasım 2022, ss.299, (Özet Bildiri)

9. Inhibition profile of the antiviral drug foscarnet to cholinesterase enzymes

YILDIRIM E., TÜRKEŞ C.

5th International Eurasian Conference on Biological and Chemical Sciences (EurasianBioChem 2022), Ankara, Türkiye, 23 - 25 Kasım 2022, ss.289, (Özet Bildiri)

10. Synthesis and Characterization of Novel Triazol-Oksadiazol-Sulfonamid Derivatives: Determination of Their Antidiabetic and Radical Scavenging Activities

IŞIK M., TÜRKEŞ C., ARSLAN M., FIRAT M., BEYDEMİR Ş.

4th Eurasia Biochemical Approaches & Technologies (EBAT) Congress, Antalya, Türkiye, 3 - 06 Kasım 2022, ss.63, (Özet Bildiri)

11. Novel Schiff Base Metal Complexes as Cholinesterase Inhibitors

Tuna Yıldırım S., Türkeş C., Topal F., Topal M., Eroğlu O., Beydemir Ş.

4th Eurasia Biochemical Approaches & Technologies (EBAT) Congress, Antalya, Türkiye, 3 - 06 Kasım 2022, ss.217, (Özet Bildiri)

12. Purification of Lipoxygenase Enzyme from Quinoa (Chenopodium Quinoa Willd.) and Investigation of the Inhibition Effects of Some Newly Synthesized Schiff Bases on Enzyme Activity

Ereminsoy E., Demir Y., Tuna Yıldırım S., Türkeş C., Küfrevioğlu Ö. İ.

4th Eurasia Biochemical Approaches & Technologies (EBAT) Congress, Antalya, Türkiye, 3 - 06 Kasım 2022, ss.255, (Özet Bildiri)

13. 1,2,3-Triazole Based Sulfonamide Derivatives as Effective Inhibitors of Acetylcholinesterase Enzyme

KAKAKHAN C., TÜRKEŞ C., GÜLEÇ Ö., DEMİR Y., ARSLAN M., BEYDEMİR Ş.

4th Eurasia Biochemical Approaches & Technologies (EBAT) Congress, Antalya, Türkiye, 3 - 06 Kasım 2022, ss.87, (Özet Bildiri)

14. Investigation of In Vitro and In Silico Effects of Brown Algae Extracts on Cholinergic Enzymes Activity

ÜNAL D., IŞIK M., TÜRKEŞ C., TÜNEY KIZILKAYA İ., BEYDEMİR Ş.

4th Eurasia Biochemical Approaches & Technologies (EBAT) Congress, Antalya, Türkiye, 3 - 06 Kasım 2022, ss.28, (Özet Bildiri)

15. Metal Complexes of Novel Schiff Base: Evaluation of the Cholinesterase Inhibitory Activities

Tuna Yıldırım S., Türkeş C., Topal F., Topal M., Beydemir Ş.

4th Eurasia Biochemical Approaches & Technologies (EBAT) Congress, Antalya, Türkiye, 3 - 06 Kasım 2022, ss.241, (Özet Bildiri)

16. Biological Evaluation of Triazolo Sulfonamide Substituted Oxime Ether Derivatives as Acetylcholinesterase Inhibitors

BUZA A., TÜRKEŞ C., ARSLAN M., DEMİR Y., NIXHA A. R., BEYDEMİR Ş.

4th Eurasia Biochemical Approaches & Technologies (EBAT) Congress, Antalya, Türkiye, 3 - 06 Kasım 2022, ss.86, (Özet Bildiri)

17. Novel Sulfonamides Incorporating Β-Lactam Moiety as Carbonic Anhydrase Inhibitor

Güleç Ö., Türkeş C., Arslan M., Demir Y., Dincer B., Beydemir Ş.

The Sixth International Symposium on Pharmaceutical and Biomedical Sciences (ISPBS-6), Gaziantep, Türkiye, 26 Mayıs - 28 Haziran 2022, ss.77, (Özet Bildiri)

18. New Schiff Base Ligand-Complexes: Synthesis, Characterization, and Biological Evaluation as Cholinesterase Inhibitors

TUNA YILDIRIM S., TÜRKEŞ C., TOPAL F., TOPAL M., TÜRKMENOĞLU M., BEYDEMİR Ş.

10. Uluslararası İlaç Kimyası Kongresi, Antalya, Türkiye, 10 Mart 2022, cilt.1, ss.53, (Özet Bildiri)

19. New Schiff Base Ligand-Complexes: Synthesis, Characterization, and Biological Evaluation

Tuna Yıldırım S., Türkeş C., Kağan Yeniçeri E. K., Duran H. E., Altay A., Beydemir Ş.

3rd Eurasia Biochemical Approaches & Technologies Congress (EBAT), Antalya, Türkiye, 4 - 07 Kasım 2021, ss.98, (Özet Bildiri)

20. Novel Schiff Base Ligand-Complexes: Synthesis, Characterization, and Biological Evaluation as Aldose Reductase Inhibitors

Tuna Yıldırım S., Türkeş C., Duran H. E., Beydemir Ş.

3rd Eurasia Biochemical Approaches & Technologies Congress (EBAT), Antalya, Türkiye, 4 - 07 Kasım 2021, ss.1, (Özet Bildiri)

21. The Influence of Some Antibiotic Drugs on Aldose Reductase and Sorbitol Dehydrogenase Enzymes

Türkeş C., Demir Y., Beydemir Ş.

3rd Eurasia Biochemical Approaches & Technologies Congress (EBAT), Antalya, Türkiye, 4 - 07 Kasım 2021, ss.1, (Özet Bildiri)

22. Synthesis, Characterization, Biological Evaluation and Molecular Docking Studies of Novel Azoimine Compounds with Sulfisoxazole Backbone

Işık M., Lolak N., Akocak S., Duran H. E., Türkeş C., Durgun M., et al.

3rd Eurasia Biochemical Approaches & Technologies Congress (EBAT), Antalya, Türkiye, 4 - 07 Kasım 2021, ss.96, (Özet Bildiri)

23. Inhibition Effect of 7-deazahypoxanthine on Some Metabolic Enzymes

Demir Y., Türkeş C., Ertano B. Y., Aksakal E., Erdoğan O., Beydemir Ş.

3rd Eurasia Biochemical Approaches & Technologies Congress (EBAT), Antalya, Türkiye, 4 - 07 Kasım 2021, ss.1, (Özet Bildiri)

24. Synthesis and Biological Evaluation of Novel Schiff Base Ligand-Complexes as Potential Cholinesterase Inhibitors

Tuna Yıldırım S., Türkeş C., Duran H. E., Beydemir Ş.

3rd Eurasia Biochemical Approaches & Technologies Congress (EBAT), Antalya, Türkiye, 4 - 07 Kasım 2021, ss.1, (Özet Bildiri)

25. Synthesis and Biological Evaluation of Novel Schiff Base Ligand-Complexes as Potential Cholinesterase Inhibitors

TUNA YILDIRIM S., TÜRKEŞ C., DURAN H. E., BEYDEMİR Ş.

3rd Eurasia Biochemical Approaches & Technologies Congress (EBAT), Antalya, Türkiye, 4 - 07 Kasım 2021, (Özet Bildiri)

26. Synthesis of Novel 1-Benzyl-2-Substituted-Benzimidazole-5-Sulfonamide Derivatives and Investigation of Their Effects on Cholinesterases and Carbonic Anhydrase Enzymes

Er A., Eroğlu Y., Bozbey İ., Türkeş C.

13th International Symposium on Pharmaceutical Sciences, Ankara, Türkiye, 22 - 25 Haziran 2021, ss.56, (Özet Bildiri)

27. New Schiff Base Ligand-Complexes as Carbonic Anhydrase and Cholinesterase Enzyme Inhibitors: Synthesis, Characterization and in Vitro / in Silico Evaluation

Tuna Yıldırım S., Güğercin R. S., Duran H. E., Türkeş C.

13th International Symposium on Pharmaceutical Sciences, Ankara, Türkiye, 22 - 25 Haziran 2021, ss.107, (Tam Metin Bildiri)

28. Inhibitory Properties of Bis-thiomethylcyclohexanone Derivatives on Aldose Reductase Enzyme Activity

TÜRKEŞ C., DEMİR Y., BİÇER A., BEYDEMİR Ş., TURGUT CİN G., GÜLTEKİN M. S.

Eurasia Biochemical Approaches Technologies (EBAT) Congress, Antalya, Türkiye, 26 - 29 Ekim 2019, (Özet Bildiri)

29. Influence of Some Phenolic Compounds on Aldose Reductase and Sorbitol Dehydrogenase Enzymes

TÜRKEŞ C., DEMİR Y., BEYDEMİR Ş.

Eurasia Biochemical Approaches Technologies (EBAT) Congress, Antalya, Türkiye, 26 - 29 Ekim 2019, (Özet Bildiri)